PeopleBeatingCancer

Our Mission

PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.

Click the orange button to the right to learn more.

Learn More

Fenbendazole and Cancer: What the Research Really Shows

Share Button

Fenbendazole and Cancer: What the Research Really Shows- In recent years, fenbendazole (often shortened to “fenben”)—a veterinary anti-parasite medication—has gained attention online as a possible cancer treatment. Patient stories and social media discussions have helped fuel interest, especially among people searching for inexpensive, repurposed therapies.

But what does scientific research actually show?

This article reviews the current evidence—from laboratory studies to early clinical observations—to inform patients about where fenbendazole stands in cancer research.

I am a long-term survivor of an incurable blood cancer called multiple myeloma. I have gone to great lengths and taken great risks in an effort to manage my blood cancer.  I can understand why cancer patients hear about non-conventional therapies and want to understand more about them as possible therapies.

The post below is PeopleBeatingCancer’s effort to weigh in on the fenben and cancer debate. Please scroll down the page, post a question or a comment if you have any questions.

If you’d like to learn more about repurposed drugs and cancer treatment, click now. 

Thank you,

David Emerson

How Fenbendazole Could Treat Cancer (and Why It Might Not)

What Is Fenbendazole?

Fenbendazole is part of a class of drugs called benzimidazoles, which are widely used to treat parasitic infections in animals such as dogs, cattle, goats, and horses. It works by disrupting microtubules, structures that cells use for division and internal transport. ()

Interestingly, this mechanism is similar to how several established chemotherapy drugs work. Because rapidly dividing cancer cells rely heavily on microtubules, researchers began exploring whether fenbendazole might also affect tumor growth.

Why Researchers Became Interested in Fenbendazole

Interest in fenbendazole as a potential anti-cancer drug comes from drug repurposing, a strategy that investigates whether existing medications might treat diseases beyond their original use.

Preclinical research suggests that fenbendazole may affect cancer cells through several biological mechanisms:

Possible anti-cancer mechanisms

Researchers have reported that fenbendazole may:

  • Disrupt microtubule formation, interfering with cancer cell division
  • Reduce glucose uptake and tumor metabolism
  • Increase oxidative stress inside cancer cells
  • Trigger programmed cell death (apoptosis)
  • Interfere with cancer cell energy pathways such as glycolysis ()

These findings suggest the drug could theoretically slow or stop tumor growth in certain experimental settings.

What Laboratory Research Shows

Most of the evidence for fenbendazole’s anti-cancer effects comes from cell culture and animal studies.

For example:

  • A study found that fenbendazole inhibited proliferation and promoted apoptosis in ovarian cancer cells in laboratory experiments. ()
  • Another investigation demonstrated anti-tumor activity in ovarian cancer mouse models, particularly when the drug was delivered using nanoparticle formulations to improve its bioavailability. ()
  • Researchers studying colorectal cancer cell lines resistant to chemotherapy observed that fenbendazole triggered ferroptosis and apoptosis, suggesting possible activity against treatment-resistant tumors. ()
  • Studies in lung cancer cells found that combining fenbendazole with other metabolic drugs increased cancer cell death by activating apoptotic pathways. ()

Collectively, laboratory studies indicate that fenbendazole can damage or kill cancer cells under experimental conditions.

However, laboratory findings do not automatically translate into effective treatments for patients.

Evidence From Animal Models

Some animal studies have also reported anti-tumor activity.

For instance, researchers observed reduced tumor growth in lymphoma models when fenbendazole was combined with certain supplements in mouse experiments. ()

These results suggest the drug may influence tumor biology in living organisms—but animal results often differ from human outcomes.

Human Evidence: Still Extremely Limited

One of the most important questions for patients is:

Has fenbendazole been proven to treat cancer in humans?

At present, the answer is no.

A small case series described three patients with advanced cancers who experienced remission while using fenbendazole alongside other therapies. ()

While intriguing, case reports have major limitations:

  • They involve very small numbers of patients
  • Treatments are not controlled or randomized
  • Other therapies may explain the outcomes

As a result, researchers emphasize that clinical evidence remains insufficient to confirm effectiveness against cancer. ()

Safety Concerns and Regulatory Status

Another important issue is safety.

Fenbendazole is:

  • Approved only for veterinary use
  • Not approved for human use by the U.S. FDA
  • Not tested in large human clinical trials for cancer treatment ()

Because human dosing, toxicity, and drug interactions are not well established, experts caution that using veterinary medications without medical supervision may carry risks.

How Fenbendazole Compares to Related Drugs

Fenbendazole belongs to a family of drugs that includes:

  • mebendazole
  • albendazole
  • flubendazole

Some of these related drugs are already being studied in clinical trials for cancer, because benzimidazole compounds can interfere with tumor cell division and metabolism. ()

This means the broader drug class may hold promise—but it does not guarantee that fenbendazole itself will become an effective cancer therapy.

The Bottom Line

Here is what the research currently shows:

What looks promising

  • Fenbendazole kills cancer cells in laboratory studies
  • Some animal experiments show reduced tumor growth
  • Mechanisms suggest potential anti-cancer activity

What remains unknown

  • Whether fenbendazole works in humans
  • Safe and effective dosing
  • Which cancers might respond
  • Long-term safety

At this stage, fenbendazole should be considered an experimental idea—not a proven cancer therapy.

A Practical Perspective for Patients

For cancer patients interested in integrative or repurposed therapies, the key principle is evidence-based decision-making.

Questions worth discussing with your oncology team include:

  • Are there clinical trials studying repurposed drugs?
  • Which therapies have human evidence, not just laboratory data?
  • How might complementary strategies (nutrition, exercise, sleep, stress reduction) support treatment outcomes?

Integrative oncology focuses on combining standard treatments with evidence-supported lifestyle and supportive therapies—while avoiding interventions that may cause harm.

Recommended Reading

Research Citation Appendix

Leave a Comment:

Popular posts

Multiple Myeloma Diet
 Multiple Myeloma Multiple Myeloma Diet
Feb 15, 2022
Multiple Myeloma Second Opinion: 7 Questions Every Newly Diagnosed Patient Should Ask
 Multiple Myeloma
Nov 04, 2022
C-B-D Enhances Velcade (BORT)
 integrative therapy Multiple Myeloma
Aug 07, 2022
Can Endometrial Polyps Become Cancer? What Women Need to Know
 Endometrial Cancer
Nov 14, 2021